Clin2
NCT07606833Possibly a fitNot yet recruiting

Testing a New Medicine to Cure Stomach Bacteria Infection

HELICOBACTER PYLORI INFECTIONS

Part of Digestive system, Infections clinical trials.

This trial tests whether a new medication called anaprazole sodium, combined with other antibiotics and bismuth, can effectively cure a common stomach bacteria infection called Helicobacter pylori (H. pylori). If you have this infection and have never been treated for it before, this study might help you while contributing to medical knowledge.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
556 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have tested positive for H. pylori bacteria (confirmed by a breath test) and need treatment
  • You have never received H. pylori treatment before
  • You do not have a severe penicillin allergy or related drug allergies
  • You have not taken stomach-acid-reducing medications in the past 2 weeks or antibiotics in the past 4 weeks
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT07533422Not yet recruiting
Testing stool to treat stubborn stomach bacteria

This study helps people whose H. pylori stomach infection didn't go away after their first round of antibiotics. Researchers will test your stool to find which antibiotics work best, then prescribe a personalized treatment plan.

NCT07275827Not yet recruiting· Phase 3
Testing 3 treatments for H. pylori infection

This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.

Shibīn al Kawm
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT07068607Recruiting· Phase 4
Comparing two treatments for H. pylori infection

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Xi'an, Shaanxi

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.